Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS
移植后微小残留病灶(MRD)和T细胞嵌合状态可预测接受异基因移植治疗急性髓系白血病/骨髓增生异常综合征(AML/MDS)患者的预后。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2022009493
Loke, Justin; McCarthy, Nicholas; Jackson, Aimee; Siddique, Shamyla; Hodgkinson, Andrea; Mason, John; Crawley, Charles; Gilleece, Maria; Peniket, Andrew; Protheroe, Rachel; Salim, Rahuman; Tholouli, Eleni; Wilson, Keith; Andrew, Georgia; Dillon, Richard; Khan, Naeem; Potter, Victoria; Krishnamurthy, Pramila; Craddock, Charles; Freeman, Sylvie